HC Wainwright & Co. analyst Yi Chen downgrades Meridian Bioscience (NASDAQ:VIVO) from Buy to Neutral and raises the price target from $30 to $34.
Robinhood CEO Vlad Tenev Shares Q1 Wins: $30M Bonus Drives User Growth, New Gold Card, UK Launch And More
Robinhood paid out over $30 million to customers who transferred their brokerage accounts into the platform during the 1% transfer bonus. The company also extended its 3% match on transfers into Robinhood Retirement for Robinhood Gold customers, resulting in over 25,000 people transferring retirement assets from other brokerages.